Onconetix
Cincinnati
About Onconetix
Onconetix is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Blue Water is is developing a universal flu vaccine that will provide protection from all virulent strains and a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $58.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:ONCO
- Website: onconetix.com
- Phone: (513) 620-4101
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/onconetix-75372 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.